Multiplex real-time polymerase chain reaction for rapid detection of β-lactamase-negative, ampicillin-resistant Haemophilus influenzae

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 1, 2009, Pages 64-69

  Nakamura, Shigeki ^a   Yanagihara, Katsunori ^a   Morinaga, Yoshitomo ^a   Izumikawa, Koichi ^a   Seki, Masafumi ^a   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Kamihira, Shimeru ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

BLNAR; Multiplex real time PCR; Rapid detection

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOTIAM; CEFTAZIDIME; IMIPENEM; MEROPENEM; PIPERACILLIN; BACTERIAL PROTEIN; PRIMER DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENETIC RESISTANCE; HAEMOPHILUS INFLUENZAE; ISOLATION PROCEDURE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPUTUM EXAMINATION; STRAIN IDENTIFICATION; VALIDATION STUDY; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; EVALUATION; GENETICS; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; SPUTUM;

AMPICILLIN RESISTANCE; BACTERIAL PROTEINS; BETA-LACTAMASES; DNA PRIMERS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 65649149358     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.01.023     Document Type: Article

References (28)

1. Bartlett J.G., and Finegold S.M. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am. Rev. Respir. Dis. 117 (1978) 1019-1027
2. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07-A7. 7th ed. (2006), CLSI, Wayne, PA
3. Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., and Pasquier C. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46 (2002) 2208-2218
4. Doern G.V., Jorgensen J.H., Thornsbery C., Preston D.A., and and the H. influenzae Surveillance Group. Prevalence of antimicrobial resistance among clinical isolates of H. influenzae: a collaborative study. Diagn. Microbiol. Infect. Dis. 4 (1986) 95-107
5. Doern G.V., Brueggemann A.B., Pierce G., Horry Jr. H.P., and Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: result of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41 (1997) 292-297
6. Dworkin M.S., Park L., and Borchardt S.M. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin. Infect. Dis. 15 (2007) 810-816
7. Fluit A.C., Florijn A., Verhoef J., and Milatovic D. Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J. Antimicrob. Chemother. 56 (2005) 133-138
8. Hasegawa K., Yamamoto K., Chiba N., Kobayashi R., Nagai K., Jacobs M.R., Appelbaum P.C., Sunakawa K., and Ubukata K. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist. 29 (2003) 39-46
9. Hasegawa K., Chiba N., Kobayashi R., Murayama S.Y., Iwata S., Sunakawa K., and Ubukata K. Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 48 (2004) 1509-1514
10. Houck P.M., Bratzler D.W., Nsa W., Ma A., and Bartlett J.G. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 164 (2004) 637-644
11. Jansen W.T., Veral A., Beitsma M., Verhoef J., and Milatovic D. Longtudinal European surveillance of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58 (2006) 873-877
12. Johansson N., Kalin M., Giske C.G., and Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn. Microbiol. Infect. Dis. 60 (2008) 255-261
13. Juteau J.M., and Levesque R.C. Sequence analysis and evolutionary perspectives of ROB-1 beta-lactamase. Antimicrob. Agents Chemother. 34 (1990) 1354-1359
14. Kee C., Palladino S., Kay I., Pryce T.M., Murray R., Rello J., Gallego M., Lujan M., Muñoz-Almagro C., and Waterer G.W. Feasibility of real-time polymerase chain reaction in whole blood to identify Streptococcus pneumoniae in patients with community-acquired pneumonia. Diagn. Microbiol. Infect. Dis. 61 (2008) 72-75
15. Kubota T., Higa F., Kusano N., Nakasone I., Haranage S., Tateyama M., Yamane N., and Fujita J. Genetic analyses of beta-lactamase negative ampicillin-resistant strains of Haemophilus influenzae isolated in Okinawa, Japan. Jpn. J. Infect. Dis. 59 (2006) 36-41
16. Markowitz S.M. Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob. Agents Chemother. 17 (1980) 80-83
17. Mendelman P.M., Chaffin D.O., Stull T.L., Rubens C.E., Mack K.D., and Selanser R.K. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26 (1984) 235-244
18. Mendelman P.M., Chaffin D.O., Musser J.M., DeGriit R., Sefass D.A., and Selanser R.K. Genetic and phenotypic diversity among ampicillin-resistant, non beta-lactamase-producing nontypeable Haemophilus influenzae isolates. Infect. Immun. 55 (1987) 2585-2589
19. Mendelman P.M., Chaffin D.O., Krilov L.R., Kalaitzoglou G., Serfass D.A., Onay O., Wiley E.A., Overturf G.D., and Rubin L.G. Cefuroxime treatment failure of nontypeable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J. Infect. Dis. 162 (1990) 1118-1123
20. Nelson M.B., Apicella M.A., Murphy T.F., Vankeulen H., Spotila L.D., and Rekosh D. Cloning and sequencing of Haemophilus influenzae outer membrane protein P6. Infect. Immun. 56 (1988) 128-134
21. Osaki Y., Sanbongi Y., Ishikawa M., Kataoka H., Suzuki T., Maeda K., and Ida T. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob. Agents Chemother. 49 (2005) 2834-2839
22. Reid A.J., Simpson I.N., Harder P.H., and Aymes S.G.B. Ampicillin resistance in Haemophilus influenzae: identification of resistance mechanism. J. Antimicrob. Chemother. 20 (1987) 645-656
23. Rubin L.G., Mederios A.A., Yolken R.H., and Moxon E.R. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet 2 (1981) 1008-1010
24. Straker K., Wootton M., Simm A.M., Bennett T.M., MacGowan A.P., and Walsh T.R. Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI. J. Antimicrob. Chemother. 51 (2003) 523-530
25. Sutcliffe J.G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 3737-3741
26. Thomas W.J., McReynolds J.W., Mock C.R., and Bailey D.W. Letter-Ampicillin-resistant Haemophilus influenzae meningitis. Lancet 1 (1974) 313
27. Ubukata K., Shibasaki Y., Yamamoto K., Chiba N., Hasegawa K., Takeuchi Y., Sunakawa K., Inoue M., and Konno M. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45 (2001) 1693-1699
28. Van der Ploeg V., Gelinck L.B., Jonkers I.J., Mourer J.S., and van Dam A.P. Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism. J. Infect. (2008) (electronic publication ahead of print)